Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Actualities in Procedural Sedation: Remimazolam

NCT07362173 is registered in ClinicalTrials.gov with Iuliu Hatieganu University of Medicine and Pharmacy as lead sponsor.

NCT NCT07362173
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07362173 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Actualities in Procedural Sedation: Remimazolam
Lead sponsor
Iuliu Hatieganu University of Medicine and Pharmacy
Phase
Phase 4
Overall status
Active, not recruiting
Start date
March 1, 2025
Completion date
May 1, 2026
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

age 65 and older, asa class iii/iv patients, copd iii/iv, multiple organ failure